Financials

  • Market Capitalization 976.97 M
  • Employee 108
  • Founded 2017
  • CEO N/A
  • Website www.januxrx.com
  • Headquarter Delaware, United States
  • FIGI BBG00ZHSKH11
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.54
Relación precio/flujo de caja
85.51

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2462
SANA
Sana Biotechnology, Inc. - Common Stock
3.65 USD+0.27%-8.06%+32.73%-13.51%1.02 B USD
2478
VOR
Vor Biopharma Inc. - Common Stock
18.25 USD+1.22%-8.20%+23.73%+39.31%988.89 M USD
2483
AVTX
Avalo Therapeutics, Inc. - Common Stock
18.69 USD-1.16%-4.10%+24.52%+280.65%982.45 M USD
2486
KURA
Kura Oncology, Inc. - Common Stock
11.04 USD+1.19%-3.92%+20.26%+72.77%980.07 M USD

Noticias